Company intelligence / Profile preview

Trident Pharma Solutions

Ownership: Private
Development stage: Other

Overview

Trident BioPharm Solutions provides expert consulting across the pharmaceutical development lifecycle. Their team assists clients with regulatory submissions (including orphan drug applications), CMC strategy and authoring, due diligence for licensing/M&A, supply chain optimization, and quality assurance. They have particular expertise in specialty pharma products and complex modalities such as biologics and cell/gene therapies. Their work has supported successful regulatory interactions with agencies like MHRA/EMA/FDA for both early-stage assets and marketed products.

Modalities: Small molecule drugsBiologicsCell therapyGene therapy
Industry: Consulting

Beyond the preview

Go deeper on Trident Pharma Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Trident Pharma Solutions.

Explore the full profile